Host intestinal epithelial response to Cryptosporidium parvum

Advanced Drug Delivery Reviews

Volumn 56, Issue 6, 2004, Pages 869-884

  Deng, Mingqi ^a   Rutherford, Mark S ^a   Abrahamsen, Mitchell S ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

Author keywords

Cryptosporidium parvum; Gene expression; Intestinal epithelial cells; Microarray analysis; Mucosal immune response

Indexed keywords

BIOCHEMISTRY; CELLS; DISEASES; DRUG THERAPY; IMMUNOLOGY; PATHOLOGY;

ACQUIRED IMMUNODEFICIENCY SYNDROME (AIDS); BIOCHEMICAL PROCESSES; MORBIDITY; MORTALITY;

PROTOZOA;

ANTIINFECTIVE AGENT; BETA DEFENSIN; CELL RECEPTOR; CYTOKINE; GALACTOSE; GAMMA INTERFERON; GLYCOPROTEIN; HEAT SHOCK PROTEIN; ISOPROTEIN; LECTIN; LIGAND; MEMBRANE PROTEIN; N ACETYLGALACTOSAMINE; NITRIC OXIDE; PROSTAGLANDIN; TRANSFORMING GROWTH FACTOR BETA;

ACUTE DIARRHEA; APOPTOSIS; ASEXUAL REPRODUCTION; ASSOCIATION; BIOCHEMISTRY; CELL ACTIVITY; CELL ADHESION; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; CYTOSKELETON; EPITHELIUM CELL; EUKARYOTE; GASTROINTESTINAL TRACT; GENE EXPRESSION PROFILING; HOST CELL; HUMAN; IMMUNE RESPONSE; IMMUNOREGULATION; INTESTINE EPITHELIUM; INTESTINE INFECTION; INTESTINE MUCOSA; INTRACELLULAR SPACE; NONHUMAN; PARASITE DEVELOPMENT; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN FUNCTION; REVIEW; SEXUAL DEVELOPMENT; T LYMPHOCYTE; VERNER MORRISON SYNDROME;

EID: 1942504249     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2003.10.034     Document Type: Article

References (122)

1. Fayer R., Speer C.A., Dubey J.P. General biology of Cryptosporidium. Fayer R. Cryptosporidium and Cryptosporidiosis. 1997;1-42 CRC Press, Boca Raton, FL.
2. Colford J.M.J., Tager I.B., Hirozawa A.M., Lemp G.F., Aragon T., Petersen C. Cryptosporidiosis among patients infected with human immunodeficiency virus: factors related to symptomatic infection and survival. Am. J. Epidemiol. 144:1996;807-816.
3. Jenkins M.C., Petersen C. Molecular biology of Cryptosporidium. Fayer R. Cryptosporidium and Cryptosporidiosis. 1997;225-232 CRC Press, Boca Raton, FL.
4. Tzipori S., Griffiths J.K. Natural history and biology of Cryptosporidium parvum. Adv. Parasitol. 40:1998;5-36.
5. Riggs M.W. Recent advances in cryptosporidiosis: the immune response. Microbes Infect. 4:2002;1067-1080.
6. Lumb R., Smith K., O'Donoghue P.J., Lanser J.A. Ultrastructure of the attachment of Cryptosporidium sporozoites to tissue culture cells. Parasitol. Res. 74:1988;531-536.
7. Aji T., Flanigan T., Marshall R., Kaetzel C., Aikawa M. Ultrastructural study of asexual development of Cryptosporidium parvum in a human intestinal cell line. J. Protozool. 38:1991;82S-84S.
8. Flanigan T.P., Aji T., Marshall R., Soave R., Aikawa M., Kaetzel C. Asexual development of Cryptosporidium parvum within a differentiated human enterocyte cell line. Infect. Immun. 59:1991;234-239.
9. Hamer D.H., Ward H., Tzipori S., Pereira M.E., Alroy J.P., Keusch G.T. Attachment of Cryptosporidium parvum sporozoites to MDCK cells in vitro. Infect. Immun. 62:1994;2208-2213.
10. Nesterenko M.V., Woods K.M., Upton S.J. Effects of manganese salts on the AIDS-related pathogen, Cryptosporidium parvum in vitro and in vivo. Biol. Trace Elem. Res. 56:1997;243-253.
11. Joe A., Verdon R., Tzipori S., Keusch G.T., Ward H.D. Attachment of Cryptosporidium parvum sporozoites to human intestinal epithelial cells. Infect. Immun. 66:1998;3429-3432.
12. Langer R.C., Riggs M.W. Neutralizing monoclonal antibody protects against Cryptosporidium parvum infection by inhibiting sporozoite attachment and invasion. J. Eukaryot. Microbiol. 43:1996;76S-77S.
13. Elliot B.C., Wisnewski A.V., Johnson J., Fenwick-Smith D., Wiest P., Hamer D., Kresina T., Flanigan T.P. In vitro inhibition of Cryptosporidium parvum infection by human monoclonal antibodies. Infect. Immun. 65:1997;3933-3935.
14. Gut J., Nelson R.G. Cryptosporidium parvum sporozoites deposit trails of 11A5 antigen during gliding locomotion and shed aaA5 antigen during invasion of MDCK cells in vitro. J. Eukaryot. Microbiol. 41:1994;42S.
15. Tilley M., Upton S.J. Both CP15 and CP25 are left as trails behind gliding sporozoites of Cryptosporidium parvum (Apicomplexa). FEMS Microbiol. Lett. 120:1994;275-278.
16. Barnes D.A., Bonnin A., Huang J.X., Gousset L., Wu J., Gut J., Doyle P., Dubremetz J.F., Ward H., Petersen C. A novel multi-domain mucin-like glycoprotein of Cryptosporidium parvum mediates invasion. Mol. Biochem. Parasitol. 96:1998;93-110.
17. Bonnin A., Ojcius D.M., Souque P., Barnes D.A., Doyle P.S., Gut J., Nelson R.G., Petersen C., Dubremetz J.F. Characterization of a monoclonal antibody reacting with antigen-4 domain of gp900 in Cryptosporidium parvum invasive stages. Parasitol. Res. 87:2001;589-592.
18. Chen X.M., LaRusso N.F. Mechanisms of attachment and internalization of Cryptosporidium parvum to biliary and intestinal epithelial cells. Gastroenterology. 118:2000;368-379.
19. Cevallos A.M., Zhang X., Waldor M.K., Jaison S., Zhou X., Tzipori S., Neutra M.R., Ward H.D. Molecular cloning and expression of a gene encoding Cryptosporidium parvum glycoproteins gp40 and gp15. Infect. Immun. 68:2000;4108-4116.
20. Cevallos A.M., Bhat N., Verdon R., Hamer D.H., Stein B., Tzipori S., Pereira M.E., Keusch G.T., Ward H.D. Mediation of Cryptosporidium parvum infection in vitro by mucin-like glycoproteins defined by a neutralizing monoclonal antibody. Infect. Immun. 68:2000;5167-5175.
21. Strong W.B., Gut J., Nelson R.G. Cloning and sequence analysis of a highly polymorphic Cryptosporidium parvum gene encoding a 60-kilodalton glycoprotein and characterization of its 15- and 45-kilodalton zoite surface antigen products. Infect. Immun. 68:2000;4117-4134.
22. Spano F., Putignani L., Naitza S., Puri C., Wright S., Crisanti A. Molecular cloning and expression analysis of a Cryptosporidium parvum gene encoding a new member of the thrombospondin family. Mol. Biochem. Parasitol. 92:1998;147-162.
23. Nesterenko M.V., Woods K., Upton S.J. Receptor/ligand interactions between Cryptosporidium parvum and the surface of the host cell. Biochim. Biophys. Acta. 1454:1999;165-173.
24. Langer R.C., Riggs M.W. Cryptosporidium parvum apical complex glycoprotein CSL contains a sporozoite ligand for intestinal epithelial cells. Infect. Immun. 67:1999;5282-5291.
25. Petersen C., Gut J., Doyle P.S., Crabb J.H., Nelson R.G., Leech J.H. Characterization of a >900,000-M(r) Cryptosporidium parvum sporozoite glycoprotein recognized by protective hyperimmune bovine colostral immunoglobulin. Infect. Immun. 60:1992;5132-5138.
26. Kuhls T.L., Mosier D.A., Crawford D.L. Effects of carbohydrates and lectins on cryptosporidial sporozoite penetration of cultured cell monolayers. J. Protozool. 38:1991;74S-76S.
27. Thea D.M., Pereira M.E.A., Kotler D., Sterling C.R., Keusch G.T. Identification and partial purification of a lectin on the surface of the sporozoite Cryptosporidium parvum. J. Parasitol. 78:1992;886-893.
28. Joe A., Hamer D.H., Kelley M.A., Pereira M.E.A., Keusch G.T., Tzipori S., Ward H.D. Role of a Gal/GalNAc-specific sporozoite surface lectin in Cryptosporidium parvum-host cell interaction. J. Eukaryot. Microbiol. 41:1994;44S.
29. Naitza S., Spano F., Robson K.J.H., Crisanti A. The thrombospondin- related protein family of apicomplexan parasites: the gears of the cell invasion machinery. Parasitol. Today. 14:1998;479-484.
30. Camero L., Arrowood M., Shulaw Y., Lal A.A., Xiao L.H. Characterization of new monoclonal antibodies against Cryptosporidium parvum sporozoites. J. Eukaryot. Microbiol. 46:1999;58S-59S.
31. Deng M.Q., Templeton T.J., London N.R., Bauer C., Schroeder A.A., Abrahamsen M.S. Cryptosporidium parvum genes containing thrombospondin type 1 domains. Infect. Immun. 70:2002;6987-6995.
32. Langer R.C., Schaefer D.A., Riggs M.W. Characterization of an intestinal epithelial cell receptor recognized by the Cryptosporidium parvum sporozoite ligand CSL. Infect. Immun. 69:2001;1661-1670.
33. Riggs M.W., Stone A.L., Yount P.A., Langer R.C., Arrowood M.J., Bentley D.L. Protective monoclonal antibody defines a circumsporozoite-like glycoprotein exoantigen of Cryptosporidium parvum sporozoites and merozoites. J. Immunol. 158:1997;1787-1795.
34. Panja A., Siden E., Mayer L. Synthesis and regulation of accessory/proinflammatory cytokines by intestinal epithelial cells. Clin. Exp. Immunol. 100:1995;298-305.
35. Theriot J.A. The cell biology of infection by intracellular bacterial pathogens. Annu. Rev. Cell Dev. Biol. 11:1995;213-239.
36. Dobrowolski J.M., Sibley L.D. Toxoplasma invasion of mammalian cells is powered by the actin cytoskeleton of the parasite. Cell. 84:1996;933-939.
37. Field S.J., Pinder J.C., Clough B., Dluzewski A.R., Wilson R.J.M., Gratzer W.B. Actin in the merozoite of the malaria parasite, Plasmodium falciparum. Cell Motil. Cytoskeleton. 25:1993;43-48.
38. Christy A.H., Maalouf G.J., Marfatia S., Palek J., Wang W., Fisher D., Liu S.C. Phosphorylation of protein 4.1 in Plasmodium falciparum-infected human red blood cells. Blood. 83:1994;3339-3345.
39. Elliott D.A., Coleman D.J., Lane M.A., May R.C., Machesky L.M., Clark D.P. Cryptosporidium parvum infection requires host cell actin polymerization. Infect. Immun. 69:2001;5940-5942.
40. Marcial M.A., Madara J.L. Cryptosporidium: cellular localization, structural analysis of absorptive cell-parasite membrane-membrane interactions in guinea pigs, and suggestion of protozoan transport by M cells. Gastroenterology. 90:1986;583-594.
41. Elliott D.A., Clark D.P. Cryptosporidium parvum induces host cell actin accumulation at the host-parasite interface. Infect. Immun. 68:2000;2315-2322.
42. Wiest P.M., Johnson J.H., Flanigan T.P. Microtubule inhibitors block Cryptosporidium parvum infection of a human enterocyte cell line. Infect. Immun. 1993;4888-4890.
43. Forney J.R., DeWald D.B., Yang S., Speer C.A., Healey M.C. A role for host phosphoinositide 3-kinase and cytoskeletal remodeling during Cryptosporidium parvum infection. Infect. Immun. 67:1999;844-852.
44. Chen X.M., Huang B.Q., Splinter P.L., Cao H., Zhu G., McNiven M.A., LaRusso N.F. Cryptosporidium parvum invasion of biliary epithelia requires host cell tyrosine phosphorylation of cortactin via c-Src. Gastroenterology. 125:2003;216-228.
45. Vaux D.L., Haecker G., Strasser A. An evolutionary perspective on apoptosis. Cell. 76:1994;777-779.
46. Moss J.E., Aliprantis A.O., Zychlinsky A. The regulation of apoptosis by microbial pathogens. Int. Rev. Cytol. 187:1999;203-259.
47. DosReis G.A., Barcinski M.A. Apoptosis and parasitism: from the parasite to the host immune response. Adv. Parasitol. 49:2001;133-161.
48. Heussler V.T., Kuenzi P., Rottenberg S. Inhibition of apoptosis by intracellular protozoan parasites. Int. J. Parasitol. 31:2001;1166-1176.
49. Chen X.M., Levine S.A., Tietz P., Krueger E., McNiven M.A., Jefferson D.M., Mahle M., LaRusso N.F. Cryptosporidium parvum is cytopathic for cultured human biliary epithelia via an apoptotic mechanism. Hepatology. 28:1998;906-913.
50. Ojcius D.M., Perfettini J.L., Bonnin A., Laurent F. Caspase-dependent apoptosis during infection with Cryptosporidium parvum. Microbes Infect. 1:1999;1163-1168.
51. Widmer G., Corey E.A., Stein B., Griffiths J.K., Tzipori S. Host cell apoptosis impairs Cryptosporidium parvum development in vitro. J. Parasitol. 86:2000;922-928.
52. McCole D.F., Eckmann L., Laurent F., Kagnoff M.F. Intestinal epithelial cell apoptosis following Cryptosporidium parvum infection. Infect. Immun. 68:2000;1710-1713.
53. Chen X.M., Gores G.J., Paya C.V., LaRusso N.F. Cryptosporidium parvum induces apoptosis in biliary epithelia by a Fas/Fas ligand-dependent mechanism. Am. J. Physiol. 277:1999;G599-G608.
54. Beg A.A., Baltimore D. An essential role for NF-κB in preventing TNF-α-induced cell death. Science. 274:1996;782-784.
55. Laurent F., Eckmann L., Savidge T.C., Morgan G., Theodos C., Naciri M., Kagnoff M.F. Cryptosporidium parvum infection of human intestinal epithelial cells induces the polarized secretion of C-X-C chemokines. Infect. Immun. 65:1997;5067-5073.
56. 2 production. Infect. Immun. 66:1998;1787-1790.
57. Seydel K.B., Zhang T., Champion G.A., Fichtenbaum C., Swanson P.E., Tzipori S., Griffiths J.K., Stanley S.L. Jr. Cryptosporidium parvum infection of human intestinal xenografts in SCID mice induces production of human tumor necrosis factor α and interleukin-8. Infect. Immun. 66:1998;2379-2382.
58. Chen X.M., Levine S.A., Splinter P.L., Tietz P.S., Ganong A.L., Jobin C., Gores G.J., Paya C.V., LaRusso N.F. Cryptosporidium parvum activates nuclear factor kappaB in biliary epithelia preventing epithelial cell apoptosis. Gastroenterology. 120:2001;1774-1783.
59. Kasper L.H., Buzoni-Gatel D. Ups and downs of mucosal cellular immunity against protozoan parasites. Infect. Immun. 69:2001;1-8.
60. Shao L., Saerrano D., Mayer L. The role of epithelial cells in immune regulation in the gut. Semin. Immunol. 13:2001;163-175.
61. Theodos C.M. Innate and cell-mediated immune responses to Cryptosporidium parvum. Adv. Parasitol. 40:1998;87-119.
62. Laurent F., McCole D., Eckmann L., Kangnoff M.F. Pathogenesis of Cryptosporidium parvum infection. Microbes Infect. 2:1999;141-148.
63. McDonald V. Host cell-mediated responses to infection with Cryptosporidium. Parasite Immunol. 22:2000;597-604.
64. Jung H.C., Eckmann L., Yang S.K., Panja A., Fierer J., Morzycka-Wroblewska E., Kagnoff M.F. A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion. J. Clin. Invest. 95:1995;55-65.
65. Schuerer-Maly C.C., Eckmann L., Kagnoff M.F., Falco M.T., Maly F.E. Colonic epithelial cell lines as a source of interleukin-8: stimulation by inflammatory cytokines and bacterial lipopolysaccharide. Immunology. 81:1994;85-91.
66. Maillot C., Gargala G., Delaunay A., Ducrotte P., Brasseur P., Ballet J.J., Favennec L. Cryptosporidium parvum infection stimulates the secretion of TGF-β, IL-8 and RANTES by Caco-2 cell line. Parasitol. Res. 86:2000;947-949.
67. Deng M., Lancto C.A., Abrahamsen M.S. Cryptosporidium parvum regulation of human epithelial cell gene expression. Int. J. Parasitol. 34:2003;73-82. (submitted for publication).
68. Strober W., Kelsall B., Fuss I., Marth T., Ludviksson B., Ehrhardt R., Neurath M. Reciprocal IFN-γ and TGF-β responses regulate the occurrence of mucosal inflammation. Immunol. Today. 18:1997;61-64.
69. Dignass A.U., Podolsky D.K. Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor-β Gastroenterology. 105:1994;1323-1332.
70. Planchon S.M., Martins C.A.P., Guerrant R.L., Roche J.K. Regulation of intestinal epithelial barrier function by TGF-β1: evidence for its role in abrogating the effect of a T cell cytokine. J. Immunol. 153:1994;5730-5739.
71. Robinson P., Okhuysen P.C., Chappell C.L., Lewis D.E., Shahab I., Lahoti S., White A.C. Transforming growth factor β1 is expressed in the jejunum after experimental Cryptosporidium parvum infection in humans. Infect. Immun. 68:2000;5405-5407.
72. Roche J.K., Martins J.C.A., Cosme R., Fayer R., Guerrant R.L. Transforming growth factor β1 ameliorates intestinal epithelial barrier disruption by Cryptosporidium parvum in vitro in the absence of mucosal T lymphocytes. Infect. Immun. 68:2000;5635-5644.
73. 2α production. J. Clin. Invest. 100:1997;296-309.
74. Salzman A., Denenberg A.G., Ueta I., O'Connor M., Linn S.C., Szabo C. Induction and activity of nitric oxide synthase in cultured human intestinal epithelial monolayers. Am. J. Physiol. 270:1996;G565-G573.
75. Kolios G., Rooney M., Murphy C.T., Robertson D.A., Westwick J. Expression of inducible nitric oxide synthase activity in human colon epithelial cells: modulation by T lymphocyte derived cytokines. Gut. 43:1998;56-63.
76. Leitch G.J., He Q. Arginine-derived nitric oxide reduces fecal oocyst shedding in nude mice infected with Cryptosporidium parvum. Infect. Immun. 62:1994;5173-5176.
77. Pollok R.C., Farthing M.J., Bajaj-Elliott M., Sanderson I.R., McDonald V. Interferon-γ induces enterocyte resistance against infection by the intracellular pathogen Cryptosporidium parvum. Gastroenterology. 120:2001;99-107.
78. Hayward A.R., Chmura K., Cosyns M. Interferon-γ is required for innate immunity to Cryptosporidium parvum in mice. J. Infect. Dis. 182:2000;1001-1004.
79. Mallow E.B., Harris A., Salzman N., Russell J.P., DeBerardinis R.J., Ruchelli E., Bevins C.L. Human enteric defensins: gene structure and developmental expression. J. Biol. Chem. 271:1996;4038-4045.
80. Jia H.P., Mills J.N., Barahmand-Pour F., Nishimura D., Mallampali R.K., Wang G., Wiles K., Tack B.F., Bevins C.L., McCray P.B. Jr. Molecular cloning and characterization of rat genes encoding homologues of human β-defensins. Infect. Immun. 67:1999;4827-4833.
81. Arrowood M.J., Jaynes J.M., Healey M.C. In vitro activities of lytic peptides against the sporozoites of Cryptosporidium parvum. Antimicrob. Agents Chemother. 35:1991;224-227.
82. Tarver A.P., Clark D.P., Diamond G., Russell J.P., Erdjument-Bromage H., Tempst P., Cohen K.S., Jones D.E., Sweeney R.W., Wines M., Hwang S., Bevins C.L. Enteric β-defensin: molecular cloning and characterization of a gene with inducible intestinal epithelial cell expression associated with Cryptosporidium parvum infection. Infect. Immun. 66:1998;1045-1056.
83. Heine J., Moon H.W., Woodmansee D.B. Persistent Cryptosporidium infection in congenitally athymic (nude) mice. Infect. Immun. 43:1984;856-859.
84. Flanigan T., Whalen C., Turner J., Soave R., Toerner J., Havlir D., Kotler D. Cryptosporidium infection and CD4 counts. Ann. Intern. Med. 116:1992;840-842.
85. Waters W.R., Harp J.A. Cryptosporidium parvum infection in T-cell receptor (TCR)-α- and TCR-δ-deficient mice. Infect. Immun. 64:1996;1854-1857.
86. Kaufmann S.H. Gamma/delta and other unconventional T lymphocytes: what do they see and what do they do? Proc. Natl. Acad. Sci. USA. 93:1996;2272-2279.
87. Wallace M., Malkovsky M., Carding S.R. Gamma/delta T lymphocytes in viral infections. J. Leukocyte Biol. 58:1995;277-283.
88. Kasper L.H., Matsuura T., Fonseka S., Arruda J., Channon J.Y., Khan I.A. Induction of γ/δ T cells during acute murine infection with Toxoplasma gondii. J. Immunol. 157:1996;5521-5527.
89. Elloso M.M., van der Heyde H.C., vande Waa J.A., Manning D.D., Weidanz W.P. Inhibition of Plasmodium falciparum in vitro by human γ/δ T cells. J. Immunol. 153:1994;1187-1194.
90. Abrahamsen M.S., Lancto C.A., Walcheck B., Layton W., Jutila M.A. Localization of α/β and γ/δ T lymphocytes in Cryptosporidium parvum-infected tissues in naive and immune calves. Infect. Immun. 65:1997;2428-2433.
91. Wyatt C.R., Brackett E.J., Perryman L.E., Rice-Ficht A.C., Brown W.C., O'Rourke K.I. Activation of intestinal intraepithelial T lymphocytes in calves infected with Cryptosporidium parvum. Infect. Immun. 65:1997;185-190.
92. Waters W.R., Wannemuehler M.J., Sacco R.E., Palmer M.V., Haynes J.S., Pesch B.A., Harp J.A. Cryptosporidium parvum-induced inflammatory bowel disease of TCR-β-x TCR-δ-deficient mice. J. Parasitol. 85:1999;1100-1105.
93. Waters W.R., Palmer M.V., Wannemuehler M.J., Sacco R.E., Harp J.A. B cells are required for the induction of intestinal inflammatory lesions in TCR-α-deficient mice persistently infected with Cryptosporidium parvum. J. Parasitol. 86:2000;1073-1077.
94. Eichelberger M.C., Suresh P., Rehg J.E. Protection from Cryptosporidium parvum infection by γ/δ T cells in mice that lack α/β T cells. Comp. Med. 50:2000;270-276.
95. Adjei A.A., Curran B.C., Castro M., Shrestha A.K., Delsid L., Fritz H., Velez M., Enriquez F.J. Gamma/delta T cells and 65-kDa heat shock protein expression following Cryptosporidium parvum challenge in athymic C57BL/6J nude mice. Immunol. Lett. 72:2000;35-38.
96. Zugel U., Kaufmann S.H.E. Role of heat shock proteins in protection from and pathogenesis of infectious diseases. Clin. Microbiol. Rev. 12:1999;19-39.
97. O'Brien R.L., Born W. Heat shock proteins as antigens for γ/ δ T cells. Semin. Immunol. 3:1991;81-87.
98. Wallin R.P., Lundqvist A., More S.H., von Bonin A., Kiessling R., Ljunggren H.G. Heat-shock proteins as activators of the innate immune system. Trends Immunol. 23:2002;130-135.
99. Nagasawa H., Oka M., Maeda K., Jian-Guo C., Hisaeda H., Ito Y., Good R.A., Himeno K. Induction of heat shock protein closely correlates with protection against Toxoplasma gondii infection. Proc. Natl. Acad. Sci. USA. 89:1992;3155-3158.
100. Hisaeda H., Sakai T., Maekawa Y., Ishikawa H., Yasutomo K., Himeno K. Mechanisms of HSP65 expression induced by γ/δ T cells in murine Toxoplasma gondii infection. Pathobiology. 64:1996;198-203.
101. Sakai T., Hisaeda H., Ishikawa H., Maekawa Y., Zhang M., Nakao Y., Takeuchi T., Matsumoto K., Good R.A., Himeno K. Expression and role of heat-shock protein 65 (HSP65) in macrophages during Trypanosoma cruzi infection: involvement of HSP65 in prevention of apoptosis of macrophages. Microbes Infect. 1:1999;419-427.
102. Zhang M., Hisaeda H., Sakai T., Li Y., Ishikawa H., Hao Y.P., Nakano Y., Ito Y., Himeno K. CD4+ T cells are required for HSP65 expression in host macrophages and for protection of mice infected with Plasmodium yoelii. Parasitol. Int. 50:2001;201-209.
103. Ravagnan L., Gurbuxani S., Susin S.A., Maisse C., Daugas E., Zamzami N., Mak T., Jaattela M., Penninger J.M., Garrido C., Kroemer G. Heat-shock protein 70 antagonizes apoptosis-inducing factor. Nat. Cell Biol. 3:2001;839-843.
104. Hisaeda H., Sakai T., Ishikawa H., Maekawa Y., Yasutomo K., Good R.A., Himeno K. Heat shock protein 65 induced by T cells prevents apoptosis of macrophages and contributes to host defense in mice infected with Toxoplasma gondii. J. Immunol. 159:1997;2375-2381.
105. White A.C., Robinson P., Okhuysen P.C., Lewis D.E., Shahab I., Lahoti S., DuPont H.L., Chappell C.L. Interferon-γ expression in jejunal biopsies in experimental human cryptosporidiosis correlates with prior sensitization and control of oocyst excretion. J. Infect. Dis. 181:2000;701-709.
106. Wyatt C.R., Brackett E.J., Savidge J. Evidence for the emergence of a type-1-like immune response in the intestinal mucosa of calves recovering from cryptosporidiosis. J. Parasitol. 87:2001;90-95.
107. Chen W., Harp J.A., Harmsen A.G. Requirements for CD4+ cells and γ-interferon in resolution of established Cryptosporidium parvum infection in mice. Infect. Immun. 61:1993;3928-3932.
108. McDonald V., Bancroft G. Mechanisms of innate and acquired resistance to Cryptosporidium parvum infection in SCID mice. Parasite Immunol. 16:1994;315-320.
109. Lacroix S., Mancassola R., Naciri M., Laurent F. Cryptosporidium parvum-specific mucosal immune response in C57BL/6 neonatal and γ-interferon-deficient mice: role of tumor necrosis factor α in protection. Infect. Immun. 69:2001;1635-1642.
110. Robinson P., Okhuysen P.C., Chappell C.L., Lewis D.E., Shahab I., Janecki A., White A.C. Jr. Expression of tumor necrosis factor α and interleukin 1β in jejuna of volunteers after experimental challenge with Cryptosporidium parvum correlates with exposure but not with symptoms. Infect. Immun. 69:2001;1172-1174.
111. Brown P., Botstein D. Exploring the new world of the genome with DNA microarrays. Nat. Genet. 21:1999;33-37.
112. Harrington C.A., Rosenow C., Retief J. Monitoring gene expression using DNA microarrays. Curr. Opin. Microbiol. 3:2000;285-291.
113. Blader I.J., Manger I.D., Boothroyd J.C. Microarray analysis reveals previously unknown changes in Toxoplasma gondii-infected human cells. J. Biol. Chem. 276:2001;24223-24231.
114. Gail M., Gross U., Bohne W. Transcriptional profile of Toxoplasma gondii-infected human fibroblasts as revealed by gene-array hybridization. Mol. Genet. Genom. 265:2001;905-912.
115. Sibley L.D., Mordue D.G., Su C., Robben P.M., Howe D.K. Genetic approaches to studying virulence and pathogenesis in Toxoplasma gondii. Philos. Trans. R Soc. Lond. B Biol. Sci. 357:2002;81-88.
116. Min W., Lillehoj H.S., Kim S., Zhu J.J., Beard H., Alkharouf N., Matthews B.F. Profiling local gene expression changes associated with Eimeria maxima and Eimeria acervulina using cDNA microarray. Appl. Microbiol. Biotechnol. 2003.
117. Ponnuraj E.M., Hayward A.R. Intact intestinal mRNAs and intestinal epithelial cell esterase, but not Cryptosporidium parvum, reach mesenteric lymph nodes of infected mice. J. Immunol. 167:2001;5321-5328.
118. Ponnuraj E.M., Hayward A.R. Requirement for TNF-Tnfrsf1 signaling for sclerosing cholangitis in mice chronically infected by Cryptosporidium parvum. Clin. Exp. Immunol. 128:2002;416-420.
119. Deng M., Abrahamsen M.S. Microarray-based expression analysis of human epithelial cell response to Cryptosporidium parvum infection. J. Eukaryot. Microbiol. 2001;42S-43S. (Suppl.).
120. Kapel N., Huneau J.F., Magne D., Tome D., Gobert J.G. Cryptosporidiosis-induced impairment of ion transport and Na+-glucose absorption in adult immunocompromised mice. J. Infect. Dis. 176:1997;834-837.
121. Blikslager A., Hunt E., Guerrant R., Rhoads M., Argenzio R. Glutamine transporter in crypts compensates for loss of villus absorption in bovine cryptosporidiosis. Am. J. Physiol. Gastrointest. Liver Physiol. 281:2001;G645-G653.
122. Barbot L., Windsor E., Rome S., Tricottet V., Reynes M., Topouchian A., Huneau J.F., Gobert J.G., Tome D., Kapel N. Intestinal peptide transporter PepT1 is over-expressed during acute cryptosporidiosis in suckling rats as a result of both malnutrition and experimental parasite infection. Parasitol. Res. 89:2003;364-370.